Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Model
β Scribed by Suniket V. Fulzele; Abhijit Chatterjee; Madhu Sudhan Shaik; Tanise Jackson; Mandip Singh
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 734 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0724-8741
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We have previously described the development and testing of a monoclonal antiβhuman CD54 antibody (UV3) in SCID mice xenografted with human multiple myeloma, lymphoma, and melanoma cell lines. In all 3 cases, UV3 was highly effective at slowing the growth of tumors and/or prolonging sur
## Abstract Berberine has been shown to have antiβcarcinogenic effects. Since p53 is the most commonly mutated tumor suppressor gene, and a lack of functional p53 is associated with an increased risk of cancer development, we examined the effects of berberine on p53βpositive and p53βdeficient nonβs
Overall prognosis in human NSCLC remains poor. Antiangiogenic treatment has become a promising concept for the treatment of solid malignancies. Our purpose was to evaluate the efficacy of recombinant HSENDO for the treatment of human NSCLC in an orthotopic murine xenotransplantation model. The effic
## Abstract The monoclonal antibody (MAb) SEN3I, a mouse IgG~1~ which recognizes the clusterβ5a antigen on smallβcell lung cancer (SCLC) cells, was used to prepare a selective and potent blocked ricin immunotoxin. In a series of experiments __in__ vitro and in a SCLC xenograft model in nude mice, t